Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Hepatic Cancers”

193 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 193 results

Not applicableStudy completedNCT01353300
What this trial is testing

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Who this might be right for
Brain and Central Nervous System TumorsHereditary Wilms TumorKidney Cancer+4 more
Children's Oncology Group 31
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)UnknownNCT03839550
What this trial is testing

Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Not applicableStudy completedNCT07224737
What this trial is testing

Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
City of Hope Medical Center 230
Not applicableUnknownNCT05546619
What this trial is testing

Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection

Who this might be right for
Hepatocellular Carcinoma
Sulai Liu 30
Not applicableStudy completedNCT01034865
What this trial is testing

Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer

Who this might be right for
Carcinoma, Hepatocellular
Stanford University 750
Not applicableUnknownNCT00720668
What this trial is testing

The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma

Who this might be right for
Hepatitis BHepatocellular Carcinoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)UnknownNCT04213118
What this trial is testing

Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence

Who this might be right for
Hepatocellular CarcinomaTACEAnlotinib
First Affiliated Hospital Xi'an Jiaotong University 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07475026
What this trial is testing

Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 198
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Not applicableActive Not RecruitingNCT05410353
What this trial is testing

Choosing Healthy Activities and Lifestyle Management Through Portal Support

Who this might be right for
Weight LossOverweight and ObesityBehavior, Health
University of Tennessee 229
Not applicableNot Yet RecruitingNCT06356623
What this trial is testing

A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer

Who this might be right for
Nausea and Vomiting, PostoperativeLiver Cancer
Shanghai Zhongshan Hospital 476
Not applicableStudy completedNCT03186703
What this trial is testing

Evaluating the Impact of the McMaster Optimal Aging Portal on Cancer Prevention Behaviours in Underserved Populations

Who this might be right for
Cancer
McMaster University 549
Testing effectiveness (Phase 2)Study completedNCT02447679
What this trial is testing

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Who this might be right for
Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaAdverse Reaction to Drug+1 more
Chang Gung Memorial Hospital 40
Not applicableLooking for participantsNCT05095714
What this trial is testing

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

Who this might be right for
Hepatocellular CarcinomaLiver CancerCirrhosis+1 more
Assistance Publique - Hôpitaux de Paris 944
Not applicableNot Yet RecruitingNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100
Not applicableStudy completedNCT06555510
What this trial is testing

Preoperative Edema is a Significant Risk Factor for Post-hepatectomy Complications

Who this might be right for
Patients Who Underwent Hepatectomy for Liver Neoplasms
Kochi University 414
Not applicableNot Yet RecruitingNCT07010588
What this trial is testing

Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk

Who this might be right for
Hepatocellular Carcinoma (HCC)Magnetic Resonance Imaging (MRI)Randomized Controlled Trial
Peking University People's Hospital 1,389
Testing effectiveness (Phase 2)UnknownNCT06059885
What this trial is testing

Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC

Who this might be right for
Liver Neoplasms
Beijing 302 Hospital 60
Not applicableUnknownNCT04160897
What this trial is testing

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Who this might be right for
Hepatitis B, ChronicHepatocellular CarcinomaCompensated Cirrhosis
Qing XIe 4,000
Load More Results